​

Roivant Sciences (ROIV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Roivant Sciences Revenue Highlights

Latest Revenue (Y)

$8.26M

Latest Revenue (Q)

$2.00M

Main Segment (Y)

Reportable Segment

Roivant Sciences Revenue by Period

Roivant Sciences Revenue by Year

DateRevenueChange
2026-03-31$8.26M-71.57%
2025-03-31$29.05M-11.19%
2024-03-31$32.71M-46.62%
2023-03-31$61.28M10.84%
2022-03-31$55.29M132.34%
2021-03-31$23.80M-64.85%
2020-03-31$67.69M-

Roivant Sciences generated $8.26M in revenue during NA 2025, up -71.57% compared to the previous quarter, and up 34.71% compared to the same period a year ago.

Roivant Sciences Revenue by Quarter

DateRevenueChange
2025-12-31$2.00M27.24%
2025-09-30$1.57M-27.60%
2025-06-30$2.17M-71.33%
2025-03-31$7.57M-16.06%
2024-12-31$9.02M101.52%
2024-09-30$4.47M-43.99%
2024-06-30$7.99M-11.42%
2024-03-31$9.02M-42.04%
2023-12-31$15.56M326.59%
2023-09-30$3.65M-83.13%
2023-06-30$21.62M-21.01%
2023-03-31$27.38M60.54%
2022-12-31$17.05M21.91%
2021-09-30$13.99M80.83%
2021-06-30$7.74M-48.93%
2021-03-31$15.15M163.41%
2020-12-31$5.75M334.62%
2020-09-30$1.32M-16.05%
2020-06-30$1.58M-97.50%
2020-03-31$62.95M-

Roivant Sciences generated $2.00M in revenue during Q3 2025, up 27.24% compared to the previous quarter, and up 44.67% compared to the same period a year ago.

Roivant Sciences Revenue Breakdown

Roivant Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 26Mar 24Mar 23
Reportable Segment$8.26M--
Product-$75.06M$28.01M
License, Milestone and Other Revenue-$49.74M-

Roivant Sciences's latest annual revenue breakdown by segment (product or service), as of Mar 26: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 26Dec 25Jun 24Dec 23Sep 23Jun 23
Reportable Segment$4.69M$2.00M----
Product Revenue, Net--$18.37M$20.67M$18.42M$16.66M

Roivant Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Reportable Segment (100.00%).

Roivant Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAZZJazz Pharmaceuticals$4.27B$1.07B
EXASExact Sciences$3.25B$850.74M
RPRXRoyalty Pharma$2.38B$609.29M
MRNAModerna$1.94B$389.00M
IONSIonis Pharmaceuticals$944.00M$246.09M
BBIOBridgeBio Pharma$362.37M$180.60M
ASNDAscendis Pharma$266.72M$95.89M
RNAAtrium Therapeutics$18.75M$12.47M
ROIVRoivant Sciences$8.26M$2.00M
RVMDRevolution Medicines--
SMMTSummit Therapeutics--

ROIV Revenue FAQ

What is Roivant Sciences’s yearly revenue?

Roivant Sciences's yearly revenue for 2025 was $8.26M, representing a decrease of -71.57% compared to 2024. The company's yearly revenue for 2024 was $29.05M, representing a decrease of -11.19% compared to 2023. ROIV's yearly revenue for 2023 was $32.71M, representing a decrease of -46.62% compared to 2022.

What is Roivant Sciences’s quarterly revenue?

Roivant Sciences's quarterly revenue for Q3 2025 was $2M, a 27.24% increase from the previous quarter (Q2 2025), and a -77.83% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.57M, a -27.60% decrease from the previous quarter (Q1 2025), and a -64.89% decrease year-over-year (Q2 2024). ROIV's quarterly revenue for Q1 2025 was $2.17M, a -71.33% decrease from the previous quarter (Q4 2024), and a -72.84% decrease year-over-year (Q1 2024).

What is Roivant Sciences’s revenue growth rate?

Roivant Sciences's revenue growth rate for the last 3 years (2023-2025) was -74.75%, and for the last 5 years (2021-2025) was -85.06%.

What are Roivant Sciences’s revenue streams?

Roivant Sciences's revenue streams in r 26 are Reportable Segment

What is Roivant Sciences’s main source of revenue?

For the fiscal year ending Mar 26, the largest source of revenue of Roivant Sciences was Reportable Segment. This segment made a revenue of $8.26M, representing 100.00% of the company's total revenue.